Gil Blum
Stock Analyst at Needham
(3.23)
# 1,391
Out of 5,008 analysts
416
Total ratings
39.14%
Success rate
4.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterates: Buy | $70 | $49.22 | +42.23% | 20 | Oct 3, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $8 → $10 | $4.72 | +111.86% | 30 | Oct 2, 2025 | |
| ABSI Absci | Maintains: Buy | $9 → $8 | $3.74 | +113.90% | 5 | Aug 13, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.49 | +571.14% | 29 | Jul 21, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $70.62 | +14.70% | 24 | Jul 8, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $2.90 | +520.69% | 6 | May 15, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $85.21 | +23.22% | 23 | Dec 10, 2024 | |
| FOLD Amicus Therapeutics | Upgrades: Buy | $14 | $8.16 | +71.57% | 7 | Sep 18, 2025 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $8 | $5.23 | +52.96% | 25 | Sep 11, 2025 | |
| IMAB I-Mab | Reiterates: Buy | $6 | $4.37 | +37.30% | 17 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.23 | +140.77% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.06 | +385.44% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $23.12 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.14 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $5 | $1.95 | +156.41% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.39 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $9.74 | +310.68% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $9.83 | +174.67% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $34.22 | +107.48% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.97 | +356.85% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.45 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.29 | +287.60% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $6.13 | +683.38% | 9 | Aug 2, 2024 |
Celcuity
Oct 3, 2025
Reiterates: Buy
Price Target: $70
Current: $49.22
Upside: +42.23%
Taysha Gene Therapies
Oct 2, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $4.72
Upside: +111.86%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.74
Upside: +113.90%
Autolus Therapeutics
Jul 21, 2025
Reiterates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
CRISPR Therapeutics AG
Jul 8, 2025
Reiterates: Buy
Price Target: $81
Current: $70.62
Upside: +14.70%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $2.90
Upside: +520.69%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $85.21
Upside: +23.22%
Amicus Therapeutics
Sep 18, 2025
Upgrades: Buy
Price Target: $14
Current: $8.16
Upside: +71.57%
Recursion Pharmaceuticals
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $5.23
Upside: +52.96%
I-Mab
Sep 8, 2025
Reiterates: Buy
Price Target: $6
Current: $4.37
Upside: +37.30%
Aug 13, 2025
Reiterates: Buy
Price Target: $15
Current: $6.23
Upside: +140.77%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.06
Upside: +385.44%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $23.12
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.14
Upside: -
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $1.95
Upside: +156.41%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.39
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $9.74
Upside: +310.68%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $9.83
Upside: +174.67%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $34.22
Upside: +107.48%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.97
Upside: +356.85%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.45
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $6.13
Upside: +683.38%